27 November 2025 The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody ...

Joining an expanding IP litigation practice, the new partner adds experience in patent, SPC and multi-jurisdictional disputes ...

14 November 2025 In-house counsel from AstraZeneca, BAT and Novartis say that investing in AI now will pay off in time saved, ...

Even when legal teams do include women, the judges say they don’t always see or hear them, emphasising that visibility is ...

A regulatory counsel with nine years at the FDA and over two decades of patent experience at a US law firm in Washington DC, ...

Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently ...

Regeneron and Bayer suffered a UK setback as the court followed others in Europe in its interpretation of the so-called SPC ...

The USPTO’s ‘settled expectations’ rule is anything but settled, argues Andrew Zappia of Troutman Pepper Locke. Already ...

8 October 2025 A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their ...

The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step. Already registered?

22 September 2025 The pharma giant invalidates a university's patent while gaining FDA approval for a new subcutaneous ...